Safety and immunogenicity of a high-dose quadrivalent influenza vaccine administered concomitantly with a third dose of the mRNA-1273 SARS-CoV-2 vaccine in adults aged ≥65 years: a phase 2, randomised, open-label study.

ABSTRACT:

SUBMITTER: Izikson R 

PROVIDER: S-EPMC8803382 | biostudies-literature | 2022 Apr

REPOSITORIES: biostudies-literature